# Mfsd2a is important for maintaining epidermal homeostasis

**Authors:** Bernice H. Wong, Kunal Mishra, Cheen Fei Chin, Dwight L. A. Galam, Bryan C. Tan, Mei Ding, Federico Torta, Jacques Behmoaras, Alvin W. C. Chua, David L. Silver

PMC · DOI: 10.1073/pnas.2531159123 · Proceedings of the National Academy of Sciences of the United States of America · 2026-02-19

## TL;DR

This study shows that Mfsd2a helps skin cells take up a type of phospholipid, which is important for maintaining healthy skin and preventing conditions like eczema.

## Contribution

The study identifies Mfsd2a as a key transporter for lysophosphatidylcholines in epidermal keratinocytes, linking it to epidermal homeostasis.

## Key findings

- Mfsd2a deficiency in mice leads to dermatitis and impaired epidermal desquamation.
- Mfsd2a is crucial for keratinocyte uptake of plasma-derived lysophosphatidylcholines.
- LPCs promote keratinocyte differentiation in a Mfsd2a-dependent manner in human cells.

## Abstract

Disruption of the epidermal skin barrier is a common clinical feature for prevalent diseases such as atopic dermatitis and psoriasis. Epidermal function is reliant on dietary linoleic acid and has a high demand for phospholipids, but whether epidermal keratinocytes take up plasma-derived phospholipid such as the abundant plasma lysophosphatidylcholines (LPC) is not known. This study utilized mouse models of epidermal Mfsd2a deficiency, histological and gene expression analysis, untargeted lipidomics, and human keratinocyte cultures, demonstrating that the epidermal keratinocytes acquire plasma-derived LPC via Mfsd2a mediated transport; and this pathway is important for maintaining a normal phospholipidome and proper epidermal differentiation. The findings in this study raise the possibility that LPCs might have therapeutic benefit for epidermal health.

The skin epidermis is a multilayered lipid rich organ completely reliant on exogenous delivery and uptake of the essential fatty linoleate for the synthesis of acylceramides required for barrier function. Disruption of the epidermal skin barrier is a common clinical feature for prevalent diseases such as atopic dermatitis and psoriasis. The granulosum layer of the epidermis contains specialized secretory keratinocytes that synthesize and secrete lamellar bodies (LB), making it likely that this epidermal layer has a high demand for phosphatidylcholine. While the pathway for acylceramide biosynthesis and roles in barrier formation has been largely elucidated, the mechanisms by which keratinocytes acquire phospholipid for the demands of lipid barrier maintenance and repair are not entirely understood. Here, we demonstrate that Mfsd2a, a lysophosphatidylcholine (LPC) transporter, is predominantly expressed in keratinocytes and mediates the uptake of a plasma-derived LPC fluorescent probe. Epidermal-specific deficiency of Mfsd2a in mice resulted in dermatitis and defective desquamation of the epidermis, and inducible deletion of Mfsd2a in primary mouse keratinocytes in vitro prevented their epidermal stratification. Untargeted lipidomic analysis indicated that Mfsd2a deficiency resulted in a significantly altered phospholipidome, with specific reductions in linoleic acid in phosphatidylcholine and triglycerides in the epidermis. Functional studies using primary human keratinocytes demonstrated that LPC-oleate and LPC-linoleate promoted keratinocyte differentiation in a Mfsd2a-dependent manner. Our findings identify a pathway by which keratinocytes acquire plasma-derived LPC via Mfsd2a transport for the maintenance of normal keratinocyte phosphatidylcholine pools and for optimal keratinocyte differentiation.

## Linked entities

- **Genes:** MFSD2A (MFSD2 lysolipid transporter A, lysophospholipid) [NCBI Gene 84879]
- **Chemicals:** lysophosphatidylcholines (PubChem CID 5311264), linoleic acid (PubChem CID 5280450)
- **Diseases:** atopic dermatitis (MONDO:0004980), psoriasis (MONDO:0005083)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Loricrin (loricrin cornified envelope precursor protein) [NCBI Gene 16939] {aka Lor}, LPCAT3 (lysophosphatidylcholine acyltransferase 3) [NCBI Gene 10162] {aka C3F, LPCAT, LPLAT 5, LPLAT12, LPSAT, MBOAT5}, Sprr1a (small proline-rich protein 1A) [NCBI Gene 20753] {aka SPR1a, mSPRR1A}, Pla2g2f (phospholipase A2, group IIF) [NCBI Gene 26971] {aka GIIFsPLA2, sPLA2-IIF}, Trim27 (tripartite motif-containing 27) [NCBI Gene 19720] {aka Gm19403, Rfp}, Sprr2a1 (small proline-rich protein 2A1) [NCBI Gene 20755] {aka Sprr2a, Sprr2a3}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, Pdgfra (platelet derived growth factor receptor, alpha polypeptide) [NCBI Gene 18595] {aka CD140a, Pdgfr-2}, Krt6a (keratin 6A) [NCBI Gene 16687] {aka 2310016L08Rik, CK-6A, K6A, K6[a], Krt2-6a, Krt2-6c}, Cyp4f39 (cytochrome P450, family 4, subfamily f, polypeptide 39) [NCBI Gene 320997] {aka 4732474A20Rik}, Abhd5 (abhydrolase domain containing 5) [NCBI Gene 67469] {aka 1300003D03Rik, 2010002J10Rik, CGI-58, IECN5, NCIE2}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Krt10 (keratin 10) [NCBI Gene 16661] {aka D130054E02Rik, K10, K1C1, Krt-1.10, Krt1-10}, Mfsd2a (MFSD2 lysolipid transporter A, lysophospholipid) [NCBI Gene 76574] {aka 1700018O18Rik, Mfsd2, NLS1}, RPL13A (ribosomal protein L13a) [NCBI Gene 23521] {aka L13A, TSTA1, uL13}, TGM1 (transglutaminase 1) [NCBI Gene 7051] {aka ARCI1, ICR2, KTG, LI, LI1, TGASE}, Krt1 (keratin 1) [NCBI Gene 16678] {aka Krt-2.1, Krt2-1, Krt86}, KRT1 (keratin 1) [NCBI Gene 3848] {aka AEI2, CK1, EHK, EHK1, EPPK, K1}, Ivl (involucrin) [NCBI Gene 16447] {aka 1110019C06Rik}, Gba1 (glucosylceramidase beta 1) [NCBI Gene 14466] {aka GC, GCase, GLUC, Gba, betaGC}, Pnpla1 (patatin-like phospholipase domain containing 1) [NCBI Gene 433091], Krt6 (keratin 6) [NCBI Gene 110309] {aka K6, Krt-2.6, Krt2-6}, MFSD2A (MFSD2 lysolipid transporter A, lysophospholipid) [NCBI Gene 84879] {aka HsMFSD2A, MCPH15, MFSD2, NEDMISBA, NLS1, SLC59A1}, Mapk3 (mitogen-activated protein kinase 3) [NCBI Gene 26417] {aka Erk-1, Erk1, Ert2, Esrk1, Mnk1, Mtap2k}, IVL (involucrin) [NCBI Gene 3713], Dgat2 (diacylglycerol O-acyltransferase 2) [NCBI Gene 67800] {aka 0610010B06Rik, ARAT, DGAT-2}, FLG (filaggrin) [NCBI Gene 2312] {aka ATOD2, FLG-1, FLG1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, ORAI1 (ORAI calcium release-activated calcium modulator 1) [NCBI Gene 84876] {aka CRACM1, IMD9, ORAT1, TAM2, TMEM142A}, Slc27a4 (solute carrier family 27 (fatty acid transporter), member 4) [NCBI Gene 26569] {aka ACSVL4, FATP4}, Flg (filaggrin) [NCBI Gene 14246] {aka ft}, KRT10 (keratin 10) [NCBI Gene 3858] {aka BCIE, BIE, CK10, EHK, EHK2, EHK2A}, Krt5 (keratin 5) [NCBI Gene 110308] {aka 3300001P10Rik, CK5, K5, Krt2-5, Tfip8}
- **Diseases:** ichthyosis (MESH:D007057), epidermal hyperplasia (MESH:D006965), Parakeratosis (MESH:D010241), atopic dermatitis (MESH:D003876), Chanarin-Dorfman syndrome (MESH:C536560), dehydration (MESH:D003681), Familial Microcephaly 15 (OMIM:616486), hypomyelination (MESH:D003711), intellectual disability (MESH:D008607), CGI58 deficiency (MESH:D007153), eczema (MESH:D004485), psoriasis (MESH:D011565), psoriatic (MESH:D015535), Harlequin Ichthyosis (MESH:D017490), microcephaly (MESH:D008831), dermatitis (MESH:D003872), alopecia (MESH:D000505), hyperkeratosis (MESH:D017488), postnatal lethality (MESH:D019052), skin diseases (MESH:D012871), congenital ichthyosis (MESH:C538281)
- **Chemicals:** calcium (MESH:D002118), 4-OHT (MESH:C032278), magnesium (MESH:D008274), SL (MESH:D013107), LPC (MESH:D008244), PBS (MESH:D007854), DHA (MESH:D004281), chloroform (MESH:D002725), PFA (MESH:C003043), Lipid (MESH:D008055), CO2 (MESH:D002245), 4-hydroxytamoxifen (MESH:C016601), PC (MESH:C053518), fatty acid (MESH:D005227), acetone (MESH:D000096), phosphatidylcholine (MESH:D010713), fatty acid 18:1 (MESH:D009829), FAD (MESH:D005182), PUFAs (MESH:D005231), LPC22:6 (MESH:C470482), H&amp;E (MESH:D006371), sphingomyelin (MESH:D013109), LPC-oleate (-), mono- (MESH:C106553), ceramide (MESH:D002518), cholesterol (MESH:D002784), SDS (MESH:D012967), CaCl2 (MESH:D002122), LPE (MESH:C008301), glucosylceramides (MESH:D005963), water (MESH:D014867), PL (MESH:D010743), PNAS (MESH:D020135), triglyceride (MESH:D014280), essential fatty acids (MESH:D005228), xylazine (MESH:D014991), EDTA (MESH:D004492), DPBS (MESH:C012939), Tamoxifen (MESH:D013629), PI (MESH:D010716), linoleate (MESH:D019787), methanol (MESH:D000432), paraffin (MESH:D010232)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** 3T3-J2 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_W667)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933103/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933103/full.md

## References

79 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933103/full.md

---
Source: https://tomesphere.com/paper/PMC12933103